These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 894682)
1. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone. Jiang JB; Hanson RN; Portoghese PS; Takemori AE J Med Chem; 1977 Aug; 20(8):1100-2. PubMed ID: 894682 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties. Portoghese PS; Larson DL; Jiang JB; Caruso TP; Takemori AE J Med Chem; 1979 Feb; 22(2):168-73. PubMed ID: 218009 [TBL] [Abstract][Full Text] [Related]
3. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol. Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832 [TBL] [Abstract][Full Text] [Related]
4. Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone. Chatterjie N; Inturrisi CE J Med Chem; 1975 May; 18(5):490-2. PubMed ID: 1151958 [TBL] [Abstract][Full Text] [Related]
5. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558). Fujimoto JM; Roerig S; Wang RI; Chatterjie N; Inturrisi CE Proc Soc Exp Biol Med; 1975 Feb; 148(2):443-8. PubMed ID: 1168347 [TBL] [Abstract][Full Text] [Related]
7. Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones. Pasternak GW; Hahn EF J Med Chem; 1980 Jun; 23(6):674-6. PubMed ID: 6156240 [TBL] [Abstract][Full Text] [Related]
8. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives. Vizi ES; Foldes FF; Rich J; Knoll J Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310 [TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone. Porter SJ; Somogyi AA; White JM Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of the hot plate technique to study narcotic antagonists. Heilman RD; Gray MI; Chen RP; Hahn EF; Fishman J Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):635-47. PubMed ID: 1265343 [TBL] [Abstract][Full Text] [Related]
11. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384 [TBL] [Abstract][Full Text] [Related]
12. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone. Shannon HE; Holtzman SG Psychopharmacology (Berl); 1976 Nov; 50(2):119-24. PubMed ID: 826950 [TBL] [Abstract][Full Text] [Related]